Steward Partners Investment Advisory, LLC Alaunos Therapeutics, Inc. Transaction History

Steward Partners Investment Advisory, LLC

$9.37 Billion
Q2 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.43 - $0.65 $131 - $198	-306 Reduced 1.15%	26,200 $13,000
Q1 2023 May 15, 2023	SELL	$0.46 - $0.81 $3,266 - $5,751	-7,100 Reduced 21.13%	26,506 $16,000
Q4 2022 Feb 15, 2023	SELL	$0.5 - $261.0 $1,750 - $913,500	-3,500 Reduced 9.43%	33,606 $21,000
Q3 2022 Nov 10, 2022	BUY	$1.04 - $322.5 $1,040 - $322,500	1,000 Added 2.77%	37,106 $64,000
Q2 2022 Aug 04, 2022	SELL	$0.41 - $1.24 $3,884 - $11,747	-9,474 Reduced 20.79%	36,106 $45,000
Q1 2022 May 02, 2022	SELL	$0.62 - $1.17 $360 - $679	-581 Reduced 1.26%	45,580 $30,000
Q4 2021 Feb 08, 2022	SELL	$1.09 - $1.89 $8,720 - $15,120	-8,000 Reduced 14.77%	46,161 $50,000
Q3 2021 Nov 12, 2021	BUY	$1.44 - $2.73 $19,157 - $36,319	13,304 Added 32.56%	54,161 $99,000
Q2 2021 Aug 13, 2021	SELL	$2.63 - $3.67 $10,520 - $14,680	-4,000 Reduced 8.92%	40,857 $108,000
Q1 2021 May 14, 2021	BUY	$2.82 - $5.6 $83,528 - $165,872	29,620 Added 194.4%	44,857 $161,000
Q4 2020 Feb 11, 2021	SELL	$2.09 - $3.09 $2,090 - $3,090	-1,000 Reduced 6.16%	15,237 $38,000
Q1 2020 Apr 29, 2020	SELL	$1.9 - $4.98 $11,502 - $30,148	-6,054 Reduced 27.16%	16,237 $39,000
Q4 2019 Jan 17, 2020	SELL	$3.95 - $5.35 $5,530 - $7,489	-1,400 Reduced 5.91%	22,291 $105,000
Q3 2019 Oct 30, 2019	SELL	$4.13 - $6.94 $7,169 - $12,047	-1,736 Reduced 6.83%	23,691 $101,000
Q2 2019 Jul 25, 2019	BUY	$3.98 - $6.2 $24,835 - $38,688	6,240 Added 32.52%	25,427 $148,000
Q1 2019 Apr 30, 2019	BUY	$2.0 - $4.4 $2,000 - $4,400	1,000 Added 5.5%	19,187 $73,000
Q4 2018 Jan 15, 2019	SELL	$1.61 - $3.62 $6,440 - $14,480	-4,000 Reduced 18.03%	18,187 $34,000
Q3 2018 Oct 23, 2018	SELL	$2.26 - $3.27 $5,649 - $8,175	-2,500 Reduced 10.13%	22,187 $71,000
Q1 2018 Apr 20, 2018	BUY	$3.46 - $5.14 $3,460 - $5,140	1,000 Added 4.22%	24,687 $96,000
Q2 2017 Nov 22, 2017	BUY	N/A	500 Added 2.16%	23,687 $147,000
Q4 2016 Nov 22, 2017	BUY	N/A	23,187	23,187 $124,000

Others Institutions Holding TCRT

# of Institutions

Shares Held

92.6K

Call Options Held

Put Options Held

View Full List

About Alaunos Therapeutics, Inc.

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $443M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

More about TCRT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.

Account